Business · Companies · 13 hrs ago
MBDI to list on South Korea’s Kosdaq as four firms begin IPO pricing
MBDI, a precision-medicine company, is due to list on South Korea’s Kosdaq on Nov.
24.
It uses 3D cell cultures to test how cancer cells respond to drugs and help predict treatment effects.
Its final IPO price was set at 7,000 won per share, below its planned range of 9,600 to 11,700 won.
Four other companies will conduct pricing surveys with institutional investors, which help set their IPO prices.
They are aerospace structures maker ANH Structure, cybersecurity firm Enki WhiteHat, drug developer Innovo Therapeutics and pharmaceutical company Mothers Pharmaceutical.
KMF and ANH Structure will also open share subscriptions to individual investors, on Nov.
24–25 and Nov.
27–30, respectively.
The pricing surveys and subscriptions will continue into early December, with the companies’ final prices and listing plans to follow.
MBDI is scheduled to list on South Korea’s Kosdaq market on November 24.
The 3D cell-culture precision medicine company’s offer price was set at 7,000 won, below its planned range of 9,600 to 11,700 won.
Four companies are conducting or starting institutional investor demand forecasts during the week of November 23 to 27.
KMF and ANH Structure are also scheduled to hold public share subscriptions.
- Who
- MBDI, a precision medicine company, and four firms conducting IPO demand forecasts.
- What
- MBDI is set to list on Kosdaq, while four firms are conducting institutional investor demand forecasts.
- When
- MBDI is scheduled to list on November 24, 2026. The demand forecasts take place during the week of November 23 to 27, with some continuing into December.
- Where
- South Korea’s Kosdaq market.
- Why
- Not stated
This story does not have two clearly opposing sides.
Innobotherapeutics began its institutional investor demand forecast, scheduled to continue through December 2.
Four companies are scheduled to conduct institutional investor demand forecasts during this week.
MBDI is scheduled to list on Kosdaq.
KMF is scheduled to hold its public share subscription.
- MBDI listing
- Kosdaq, November 24, 2026
- MBDI offer price
- 7,000 won per share
- MBDI planned price range
- 9,600–11,700 won per share
- Demand forecasts
- Four companies
- KMF subscription
- November 24–25